Peringatan Keamanan

Oral LD50 of 157.9mg/kg observed in rats and 175mg/kg observed in mice MSDS. Estimated oral LD50 of 35mg/kg in humans A19440. Sodium nitrite toxicity manifests as cardiovascular collapse following severe hypotension due to nitrite's vasodilatory action.

Nitrous acid

DB09112

small molecule approved investigational

Deskripsi

Nitrous acid (as sodium nitrite) is used as part of an intravenous mixture with sodium thiosulfate to treat cyanide poisoning. It is on the World Health Organization's List of Essential Medicines, a list of the most important medications needed in a basic health system. There is also research to investigate its applicability towards treatments for heart attacks, brain aneurysms, pulmonary hypertension in infants, and Pseudomonas aeruginosa infections.

Struktur Molekul 2D

Berat 47.0134
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) Half life of 0.4-0.78h [A19444].
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Reduced by deoxyhemoglobin to form nitric oxide A19442. Nitrite is also reduced to nitric oxide and further reduced to ammonia by gut bacteria A19445. Nitrite can be oxidized to nitrate by oxyhemoglobin.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

304 Data
Duloxetine The risk or severity of orthostatic hypotension and syncope can be increased when Nitrous acid is combined with Duloxetine.
Levodopa The risk or severity of hypotension and orthostatic hypotension can be increased when Nitrous acid is combined with Levodopa.
Risperidone Nitrous acid may increase the hypotensive activities of Risperidone.
Aripiprazole Aripiprazole may increase the hypotensive activities of Nitrous acid.
Aripiprazole lauroxil Aripiprazole lauroxil may increase the hypotensive activities of Nitrous acid.
Nicorandil Nicorandil may increase the hypotensive activities of Nitrous acid.
Linezolid Linezolid may increase the orthostatic hypotensive activities of Nitrous acid.
Furazolidone Furazolidone may increase the orthostatic hypotensive activities of Nitrous acid.
Procaine Procaine may increase the orthostatic hypotensive activities of Nitrous acid.
Tranylcypromine Tranylcypromine may increase the orthostatic hypotensive activities of Nitrous acid.
Phenelzine Phenelzine may increase the orthostatic hypotensive activities of Nitrous acid.
Minaprine Minaprine may increase the orthostatic hypotensive activities of Nitrous acid.
Selegiline Selegiline may increase the orthostatic hypotensive activities of Nitrous acid.
Procarbazine Procarbazine may increase the orthostatic hypotensive activities of Nitrous acid.
Moclobemide Moclobemide may increase the orthostatic hypotensive activities of Nitrous acid.
Isocarboxazid Isocarboxazid may increase the orthostatic hypotensive activities of Nitrous acid.
Rasagiline Rasagiline may increase the orthostatic hypotensive activities of Nitrous acid.
Pargyline Pargyline may increase the orthostatic hypotensive activities of Nitrous acid.
Clorgiline Clorgiline may increase the orthostatic hypotensive activities of Nitrous acid.
Iproniazid Iproniazid may increase the orthostatic hypotensive activities of Nitrous acid.
Nialamide Nialamide may increase the orthostatic hypotensive activities of Nitrous acid.
Safinamide Safinamide may increase the orthostatic hypotensive activities of Nitrous acid.
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the orthostatic hypotensive activities of Nitrous acid.
Methylene blue Methylene blue may increase the orthostatic hypotensive activities of Nitrous acid.
Hydracarbazine Hydracarbazine may increase the orthostatic hypotensive activities of Nitrous acid.
Pirlindole Pirlindole may increase the orthostatic hypotensive activities of Nitrous acid.
Toloxatone Toloxatone may increase the orthostatic hypotensive activities of Nitrous acid.
Benmoxin Benmoxin may increase the orthostatic hypotensive activities of Nitrous acid.
Mebanazine Mebanazine may increase the orthostatic hypotensive activities of Nitrous acid.
Octamoxin Octamoxin may increase the orthostatic hypotensive activities of Nitrous acid.
Pheniprazine Pheniprazine may increase the orthostatic hypotensive activities of Nitrous acid.
Phenoxypropazine Phenoxypropazine may increase the orthostatic hypotensive activities of Nitrous acid.
Pivhydrazine Pivhydrazine may increase the orthostatic hypotensive activities of Nitrous acid.
Safrazine Safrazine may increase the orthostatic hypotensive activities of Nitrous acid.
Caroxazone Caroxazone may increase the orthostatic hypotensive activities of Nitrous acid.
Harmaline Harmaline may increase the orthostatic hypotensive activities of Nitrous acid.
Brofaromine Brofaromine may increase the orthostatic hypotensive activities of Nitrous acid.
Butalbital Butalbital may increase the hypotensive activities of Nitrous acid.
Pentobarbital Pentobarbital may increase the hypotensive activities of Nitrous acid.
Secobarbital Secobarbital may increase the hypotensive activities of Nitrous acid.
Methohexital Methohexital may increase the hypotensive activities of Nitrous acid.
Thiopental Thiopental may increase the hypotensive activities of Nitrous acid.
Primidone Primidone may increase the hypotensive activities of Nitrous acid.
Methylphenobarbital Methylphenobarbital may increase the hypotensive activities of Nitrous acid.
Thiamylal Thiamylal may increase the hypotensive activities of Nitrous acid.
Phenobarbital Phenobarbital may increase the hypotensive activities of Nitrous acid.
Amobarbital Amobarbital may increase the hypotensive activities of Nitrous acid.
Hexobarbital Hexobarbital may increase the hypotensive activities of Nitrous acid.
Barbital Barbital may increase the hypotensive activities of Nitrous acid.
Barbexaclone Barbexaclone may increase the hypotensive activities of Nitrous acid.
Butabarbital Butabarbital may increase the hypotensive activities of Nitrous acid.
Aldesleukin The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nitrous acid.
Streptokinase The risk or severity of adverse effects can be increased when Streptokinase is combined with Nitrous acid.
Methyclothiazide The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Nitrous acid.
Ropinirole The risk or severity of adverse effects can be increased when Ropinirole is combined with Nitrous acid.
Morphine The risk or severity of adverse effects can be increased when Morphine is combined with Nitrous acid.
Ropivacaine The risk or severity of adverse effects can be increased when Ropivacaine is combined with Nitrous acid.
Bupivacaine The risk or severity of adverse effects can be increased when Bupivacaine is combined with Nitrous acid.
Tolcapone The risk or severity of adverse effects can be increased when Tolcapone is combined with Nitrous acid.
Olanzapine The risk or severity of adverse effects can be increased when Olanzapine is combined with Nitrous acid.
Clozapine The risk or severity of adverse effects can be increased when Clozapine is combined with Nitrous acid.
Triamterene The risk or severity of adverse effects can be increased when Triamterene is combined with Nitrous acid.
Pramipexole The risk or severity of adverse effects can be increased when Pramipexole is combined with Nitrous acid.
Spironolactone The risk or severity of adverse effects can be increased when Spironolactone is combined with Nitrous acid.
Nitric Oxide The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Nitrous acid.
Imipramine The risk or severity of adverse effects can be increased when Imipramine is combined with Nitrous acid.
Chlorpromazine The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Nitrous acid.
Nabilone The risk or severity of adverse effects can be increased when Nabilone is combined with Nitrous acid.
Sotalol The risk or severity of adverse effects can be increased when Sotalol is combined with Nitrous acid.
Amiloride The risk or severity of adverse effects can be increased when Amiloride is combined with Nitrous acid.
Clofarabine The risk or severity of adverse effects can be increased when Clofarabine is combined with Nitrous acid.
Dexmedetomidine The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Nitrous acid.
Verapamil The risk or severity of adverse effects can be increased when Verapamil is combined with Nitrous acid.
Thioridazine The risk or severity of adverse effects can be increased when Thioridazine is combined with Nitrous acid.
Amphotericin B The risk or severity of adverse effects can be increased when Amphotericin B is combined with Nitrous acid.
Furosemide The risk or severity of adverse effects can be increased when Furosemide is combined with Nitrous acid.
Tizanidine The risk or severity of adverse effects can be increased when Tizanidine is combined with Nitrous acid.
Methazolamide The risk or severity of adverse effects can be increased when Methazolamide is combined with Nitrous acid.
Tamsulosin The risk or severity of adverse effects can be increased when Tamsulosin is combined with Nitrous acid.
Sufentanil The risk or severity of adverse effects can be increased when Sufentanil is combined with Nitrous acid.
Apomorphine The risk or severity of adverse effects can be increased when Apomorphine is combined with Nitrous acid.
Mannitol The risk or severity of adverse effects can be increased when Mannitol is combined with Nitrous acid.
Isoflurane The risk or severity of adverse effects can be increased when Isoflurane is combined with Nitrous acid.
Propofol The risk or severity of adverse effects can be increased when Propofol is combined with Nitrous acid.
Conivaptan The risk or severity of adverse effects can be increased when Conivaptan is combined with Nitrous acid.
Isosorbide dinitrate The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Nitrous acid.
Bumetanide The risk or severity of adverse effects can be increased when Bumetanide is combined with Nitrous acid.
Remifentanil The risk or severity of adverse effects can be increased when Remifentanil is combined with Nitrous acid.
Etacrynic acid The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Nitrous acid.
Levosimendan The risk or severity of adverse effects can be increased when Levosimendan is combined with Nitrous acid.
Dipyridamole The risk or severity of adverse effects can be increased when Dipyridamole is combined with Nitrous acid.
Levobupivacaine The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Nitrous acid.
Isosorbide mononitrate The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Nitrous acid.
Thalidomide The risk or severity of adverse effects can be increased when Thalidomide is combined with Nitrous acid.
Iloprost The risk or severity of adverse effects can be increased when Iloprost is combined with Nitrous acid.
Papaverine The risk or severity of adverse effects can be increased when Papaverine is combined with Nitrous acid.
Nifedipine The risk or severity of adverse effects can be increased when Nifedipine is combined with Nitrous acid.
Amiodarone The risk or severity of adverse effects can be increased when Amiodarone is combined with Nitrous acid.
Amifostine The risk or severity of adverse effects can be increased when Amifostine is combined with Nitrous acid.
Diclofenamide The risk or severity of adverse effects can be increased when Diclofenamide is combined with Nitrous acid.

Target Protein

Hemoglobin subunit alpha HBA1
Hemoglobin subunit beta HBB
Myoglobin MB

Referensi & Sumber

Artikel (PubMed)
  • PMID: 1569239
    Baskin SI, Horowitz AM, Nealley EW: The antidotal action of sodium nitrite and sodium thiosulfate against cyanide poisoning. J Clin Pharmacol. 1992 Apr;32(4):368-75.
  • PMID: 10024740
    Beasley DM, Glass WI: Cyanide poisoning: pathophysiology and treatment recommendations. Occup Med (Lond). 1998 Oct;48(7):427-31.
  • PMID: 18167491
    Lundberg JO, Weitzberg E, Gladwin MT: The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov. 2008 Feb;7(2):156-67. doi: 10.1038/nrd2466.
  • PMID: 10320667
    Denninger JW, Marletta MA: Guanylate cyclase and the .NO/cGMP signaling pathway. Biochim Biophys Acta. 1999 May 5;1411(2-3):334-50.
  • PMID: 25421879
    Rix PJ, Vick A, Attkins NJ, Barker GE, Bott AW, Alcorn H Jr, Gladwin MT, Shiva S, Bradley S, Hussaini A, Hoye WL, Parsley EL, Masamune H: Pharmacokinetics, pharmacodynamics, safety, and tolerability of nebulized sodium nitrite (AIR001) following repeat-dose inhalation in healthy subjects. Clin Pharmacokinet. 2015 Mar;54(3):261-72. doi: 10.1007/s40262-014-0201-y.
  • PMID: 25803049
    Tiso M, Schechter AN: Nitrate reduction to nitrite, nitric oxide and ammonia by gut bacteria under physiological conditions. PLoS One. 2015 Mar 24;10(3):e0119712. doi: 10.1371/journal.pone.0119712. eCollection 2015.

Contoh Produk & Brand

Produk: 6 • International brands: 0
Produk
  • CVS Pharmacy Enamel Guard
    Paste, dentifrice • - • Dental • US • OTC
  • Nithiodote
    Injection, solution; Kit • - • Intravenous • US • Approved
  • Rite Aid Enamel Guard
    Paste, dentifrice • - • Dental • US • OTC
  • Sodium Nitrite
    Injection, solution • 30 mg/1mL • Intravenous • US • Approved
  • Sodium Nitrite Injection, USP
    Solution • 30 mg / mL • Intravenous • Canada • Approved
  • Wakefern Enamel Guard
    Paste, dentifrice • - • Dental • US • OTC

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul